Skip to content

In the BioHarmony Drug Report Database

Tenecteplase

TNKase, Metalyse (tenecteplase) is an enzyme pharmaceutical. Tenecteplase was first approved as TNKase on 2000-06-02. It is used to treat coronary thrombosis and myocardial infarction in the USA. It has been approved in Europe to treat myocardial infarction.
Trade Name Metalyse
Common Name Tenecteplase
Indication coronary thrombosis, myocardial infarction
Drug Class Enzymes: tissue-type plasminogen activators
Tenecteplase
Get full access now